[no definition available]
Timeframe | Studies on this Protein(%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0) | 18.7374 |
1990's | 0 (0) | 18.2507 |
2000's | 0 (0) | 29.6817 |
2010's | 0 (0) | 24.3611 |
2020's | 0 (0) | 2.80 |
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
---|---|---|---|---|---|
purpurin | Human immunodeficiency virus 1 | IC50 | 75.4340 | 1 | 0 |
1,3-ditolylguanidine | Human immunodeficiency virus 1 | IC50 | 8.3120 | 1 | 0 |
1-amino-4-hydroxyanthraquinone | Human immunodeficiency virus 1 | IC50 | 75.4240 | 2 | 0 |
diacerein | Human immunodeficiency virus 1 | IC50 | 75.4110 | 1 | 0 |
haba | Human immunodeficiency virus 1 | IC50 | 22.0200 | 1 | 0 |
fonsecin | Human immunodeficiency virus 1 | IC50 | 16.2410 | 1 | 0 |
methylnaphthazarin | Human immunodeficiency virus 1 | IC50 | 75.4205 | 2 | 0 |
oxopurpureine | Human immunodeficiency virus 1 | IC50 | 75.4180 | 1 | 0 |
2,3-diaminophenazine | Human immunodeficiency virus 1 | IC50 | 9.5290 | 1 | 0 |
LSM-28489 | Human immunodeficiency virus 1 | IC50 | 75.4270 | 1 | 0 |
N,N-diethyl-3-[(4-fluorophenyl)sulfonylamino]-4-(1-pyrrolidinyl)benzenesulfonamide | Human immunodeficiency virus 1 | IC50 | 75.4225 | 2 | 0 |
isoalloxazine | Human immunodeficiency virus 1 | IC50 | 43.9110 | 2 | 0 |